Literature DB >> 7623287

Region-specific regulation of neuropeptide mRNAs in rat limbic forebrain neurones by aldosterone and corticosterone.

A G Watts1, G Sanchez-Watts.   

Abstract

1. We have determined in adrenalectomized male rats the effects of clamping plasma corticosterone and aldosterone at various concentrations on corticotropin-releasing hormone (CRH), neurotensin/neuromedin N (NT/N) and proenkephalin (pENK) mRNAs in the hypothalamus and amygdala using semi-quantitative in situ hybridization. 2. Corticosterone differentially regulated the levels of CRH and NT/N but not pENK mRNA. These effects were cell specific. CRH mRNA was reduced in the hypothalamic paraventricular nucleus (PVH), but increased in the central nucleus of the amygdala and bed nuclei of the stria terminalis. NT/N mRNA was never seen in the PVH, whereas levels increased in the central nucleus of the amygdala, but were unaffected in the lateral hypothalamic area. In those regions expressing pENK mRNA, levels were unaffected in all treatment groups. 3. CRH mRNA in both the central nucleus of the amygdala and PVH, and NT/N mRNA in the central nucleus of the amygdala were most sensitive to plasma corticosterone concentrations of less than 120 ng ml-1, i.e. those seen away from the peak of the diurnal rhythm. In adrenalectomized animals CRH mRNA in both the central nucleus of the amygdala and PVH could be set at levels usually seen in intact animals by the same plasma concentration of corticosterone. 4. The levels of CRH mRNA in the PVH and the central nucleus of the amygdala were closely correlated, while CRH and NT/N mRNA levels were similarly correlated in the central nucleus of the amygdala suggesting the existence of a common regulatory mechanism. The ED50 of their responses to corticosterone and correlations with thymus weight suggested the operation of glucocorticoid (type II) receptor mechanisms. 5. In the absence of corticosterone, aldosterone increased CRH and NT/N mRNA accumulation in the central nucleus of the amygdala, and increased CRH but not NT/N mRNA accumulation in the PVH. Aldosterone also blunted the dose-response effects of corticosterone on CRH and NT/N mRNA levels in the central nucleus of the amygdala, but not in the PVH. 6. These results suggest that, in intact animals, adrenal steroids play a major role in maintaining the levels of neuropeptide mRNAs in the PVH, bed nuclei of the stria terminalis and central nucleus of the amygdala. The results underscore the importance of cell-specific mechanisms operating to regulate the expression of neuropeptide genes in different cell types in response to diverse physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7623287      PMCID: PMC1157955          DOI: 10.1113/jphysiol.1995.sp020698

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  34 in total

1.  Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system.

Authors:  R S Ahima; R E Harlan
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

2.  Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation.

Authors:  J M Reul; E R de Kloet
Journal:  Endocrinology       Date:  1985-12       Impact factor: 4.736

3.  Physiological regulation of peptide messenger RNA colocalization in rat hypothalamic paraventricular medial parvicellular neurons.

Authors:  A G Watts; G Sanchez-Watts
Journal:  J Comp Neurol       Date:  1995-02-20       Impact factor: 3.215

Review 4.  Functional implications of brain corticosteroid receptor diversity.

Authors:  E R de Kloet; M S Oitzl; M Joëls
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

5.  Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress.

Authors:  T Imaki; J L Nahan; C Rivier; P E Sawchenko; W Vale
Journal:  J Neurosci       Date:  1991-03       Impact factor: 6.167

6.  Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus.

Authors:  J Honkaniemi; M Pelto-Huikko; L Rechardt; J Isola; A Lammi; K Fuxe; J A Gustafsson; A C Wikström; T Hökfelt
Journal:  Neuroendocrinology       Date:  1992-04       Impact factor: 4.914

7.  The 11 beta-hydroxysteroid dehydrogenase inhibitor glycyrrhetinic acid affects corticosteroid feedback regulation of hypothalamic corticotrophin-releasing peptides in rats.

Authors:  J R Seckl; R C Dow; S C Low; C R Edwards; G Fink
Journal:  J Endocrinol       Date:  1993-03       Impact factor: 4.286

8.  Osmotic stimulation differentially affects cellular levels of corticotropin-releasing hormone and neurotensin/neuromedin N mRNAs in the lateral hypothalamic area and central nucleus of the amygdala.

Authors:  A G Watts
Journal:  Brain Res       Date:  1992-05-29       Impact factor: 3.252

9.  Diurnal CRH mRNA rhythm in the hypothalamus: decreased expression in the evening is not dependent on endogenous glucocorticoids.

Authors:  S P Kwak; M I Morano; E A Young; S J Watson; H Akil
Journal:  Neuroendocrinology       Date:  1993-01       Impact factor: 4.914

10.  Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus.

Authors:  S Makino; P W Gold; J Schulkin
Journal:  Brain Res       Date:  1994-03-21       Impact factor: 3.252

View more
  25 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

2.  Pattern of maternal circulating CRH in laboratory-housed squirrel and owl monkeys.

Authors:  M L Power; L E Williams; S V Gibson; J Schulkin; J Helfers; E P Zorrilla
Journal:  Am J Primatol       Date:  2010-11       Impact factor: 2.371

Review 3.  Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?

Authors:  Mitchel A Kling; Victoria H Coleman; Jay Schulkin
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

4.  Acute hydrocortisone treatment increases anxiety but not fear in healthy volunteers: a fear-potentiated startle study.

Authors:  Christian Grillon; Randi Heller; Elizabeth Hirschhorn; Mitchel A Kling; Daniel S Pine; Jay Schulkin; Meena Vythilingam
Journal:  Biol Psychiatry       Date:  2011-01-31       Impact factor: 13.382

5.  Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain.

Authors:  Lee Tran; Jay Schulkin; Beverley Greenwood-Van Meerveld
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

6.  Estrogen receptor beta activation prevents glucocorticoid receptor-dependent effects of the central nucleus of the amygdala on behavior and neuroendocrine function.

Authors:  Michael J Weiser; Chad D Foradori; Robert J Handa
Journal:  Brain Res       Date:  2010-04-08       Impact factor: 3.252

7.  The central and basolateral nuclei of the amygdala exhibit opposite diurnal rhythms of expression of the clock protein Period2.

Authors:  Elaine Waddington Lamont; Barry Robinson; Jane Stewart; Shimon Amir
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-03       Impact factor: 11.205

8.  Chronic stress and obesity: a new view of "comfort food".

Authors:  Mary F Dallman; Norman Pecoraro; Susan F Akana; Susanne E La Fleur; Francisca Gomez; Hani Houshyar; M E Bell; Seema Bhatnagar; Kevin D Laugero; Sotara Manalo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-15       Impact factor: 11.205

9.  The central nucleus of the amygdala and corticotropin-releasing factor: insights into contextual fear memory.

Authors:  Matthew W Pitts; Cedomir Todorovic; Thomas Blank; Lorey K Takahashi
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

Review 10.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.